Kumi Shidara

740 total citations
30 papers, 586 citations indexed

About

Kumi Shidara is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Kumi Shidara has authored 30 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 10 papers in Pathology and Forensic Medicine and 8 papers in Genetics. Recurrent topics in Kumi Shidara's work include Rheumatoid Arthritis Research and Therapies (28 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Kumi Shidara is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (28 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Kumi Shidara collaborates with scholars based in Japan and Czechia. Kumi Shidara's co-authors include Hisashi Yamanaka, Ayako Nakajima, Shigeki Momohara, Eisuke Inoue, Atsuo Taniguchi, Daisuke Hoshi, Eiichi Tanaka, Yohei Seto, Naoki Sugimoto and Eri Sato and has published in prestigious journals such as FEBS Journal, The Journal of Rheumatology and Clinical Rheumatology.

In The Last Decade

Kumi Shidara

30 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kumi Shidara Japan 16 430 126 113 99 86 30 586
Daisuke Hoshi Japan 15 586 1.4× 177 1.4× 150 1.3× 101 1.0× 142 1.7× 53 792
Gülşen Özen Türkiye 13 372 0.9× 86 0.7× 81 0.7× 65 0.7× 54 0.6× 31 590
G S Alarcón United States 12 394 0.9× 122 1.0× 93 0.8× 50 0.5× 40 0.5× 23 585
Ani John United States 14 416 1.0× 166 1.3× 70 0.6× 103 1.0× 51 0.6× 30 575
Hélène Maillard France 14 196 0.5× 78 0.6× 114 1.0× 48 0.5× 75 0.9× 48 486
K. Gadsby United Kingdom 11 348 0.8× 115 0.9× 67 0.6× 67 0.7× 26 0.3× 19 565
Naoto Yokogawa Japan 14 314 0.7× 35 0.3× 85 0.8× 100 1.0× 138 1.6× 70 603
Christopher C. Striebich United States 10 361 0.8× 74 0.6× 62 0.5× 83 0.8× 126 1.5× 20 647
Darcy S. Majka United States 10 463 1.1× 94 0.7× 49 0.4× 37 0.4× 76 0.9× 15 647
Bertrand Lioger France 12 99 0.2× 171 1.4× 72 0.6× 115 1.2× 66 0.8× 41 513

Countries citing papers authored by Kumi Shidara

Since Specialization
Citations

This map shows the geographic impact of Kumi Shidara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumi Shidara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumi Shidara more than expected).

Fields of papers citing papers by Kumi Shidara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumi Shidara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumi Shidara. The network helps show where Kumi Shidara may publish in the future.

Co-authorship network of co-authors of Kumi Shidara

This figure shows the co-authorship network connecting the top 25 collaborators of Kumi Shidara. A scholar is included among the top collaborators of Kumi Shidara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumi Shidara. Kumi Shidara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sugimoto, Naoki, Ayako Nakajima, Eisuke Inoue, et al.. (2017). Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis. Rheumatology International. 37(11). 1871–1878. 9 indexed citations
3.
Shidara, Kumi, Ayako Nakajima, Eisuke Inoue, et al.. (2016). Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis. The Journal of Rheumatology. 44(2). 147–153. 8 indexed citations
4.
Sato, Eri, Eiichi Tanaka, Yoko Shimizu, et al.. (2015). Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012. Modern Rheumatology. 25(3). 350–357. 10 indexed citations
5.
Hoshi, Daisuke, Eiichi Tanaka, Ataru Igarashi, et al.. (2015). Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database. Modern Rheumatology. 26(1). 40–45. 24 indexed citations
6.
7.
Nakajima, Ayako, Eisuke Inoue, Yoko Shimizu, et al.. (2014). Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis. Clinical Rheumatology. 34(3). 441–449. 41 indexed citations
8.
Hoshi, Daisuke, Ayako Nakajima, Kumi Shidara, et al.. (2013). Disability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab. Modern Rheumatology. 23(6). 1205–10. 9 indexed citations
9.
Seto, Yohei, Eisuke Inoue, Kumi Shidara, et al.. (2013). Functional disability can deteriorate despite suppression of disease activity in patients with rheumatoid arthritis: a large observational cohort study. Modern Rheumatology. 23(6). 1179–85. 11 indexed citations
10.
Hoshi, Daisuke, Ayako Nakajima, Kumi Shidara, et al.. (2013). Disability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab. Modern Rheumatology. 23(6). 1205–1210. 7 indexed citations
11.
Shidara, Kumi, Eisuke Inoue, Daisuke Hoshi, et al.. (2012). The Influence of Individual Joint Impairment on Functional Disability in Rheumatoid Arthritis Using a Large Observational Database of Japanese Patients. The Journal of Rheumatology. 39(3). 476–480. 14 indexed citations
12.
Hoshi, Daisuke, Ayako Nakajima, Eisuke Inoue, et al.. (2012). Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab. Modern Rheumatology. 22(1). 122–127. 17 indexed citations
13.
Tanaka, Eiichi, Daisuke Hoshi, Ataru Igarashi, et al.. (2012). Analysis of direct medical and nonmedical costs for care of rheumatoid arthritis patients using the large cohort database, IORRA. Modern Rheumatology. 23(4). 742–751. 23 indexed citations
14.
Hoshi, Daisuke, Ayako Nakajima, Eisuke Inoue, et al.. (2011). Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab. Modern Rheumatology. 22(1). 122–127. 33 indexed citations
15.
16.
Nakajima, Ayako, Eisuke Inoue, Kumi Shidara, et al.. (2011). Standard treatment in daily clinical practice for early rheumatoid arthritis improved disease activity from 2001 to 2006. Modern Rheumatology. 21(6). 594–597. 11 indexed citations
17.
Shidara, Kumi, Daisuke Hoshi, Eisuke Inoue, et al.. (2010). Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Modern Rheumatology. 20(3). 280–286. 39 indexed citations
18.
Shidara, Kumi, Eisuke Inoue, Eiichi Tanaka, et al.. (2010). Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis. Rheumatology International. 31(5). 617–622. 25 indexed citations
19.
Shidara, Kumi, Daisuke Hoshi, Eisuke Inoue, et al.. (2010). Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Modern Rheumatology. 20(3). 280–286. 48 indexed citations
20.
Okamoto, Hiroshi, et al.. (2007). Anti‐arthritis effects of vitamin K2 (menaquinone‐4) − a new potential therapeutic strategy for rheumatoid arthritis. FEBS Journal. 274(17). 4588–4594. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daisuke Hoshi Breakdown of academic impact, for papers by Gülşen Özen Breakdown of academic impact, for papers by G S Alarcón Breakdown of academic impact, for papers by Ani John Breakdown of academic impact, for papers by Hélène Maillard Breakdown of academic impact, for papers by K. Gadsby Breakdown of academic impact, for papers by Naoto Yokogawa Breakdown of academic impact, for papers by Christopher C. Striebich Breakdown of academic impact, for papers by Darcy S. Majka Breakdown of academic impact, for papers by Bertrand Lioger
Rankless by CCL
2026